Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19470628rdf:typepubmed:Citationlld:pubmed
pubmed-article:19470628lifeskim:mentionsumls-concept:C0026848lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C0012929lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C0221099lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C0231221lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C1326961lld:lifeskim
pubmed-article:19470628lifeskim:mentionsumls-concept:C1512456lld:lifeskim
pubmed-article:19470628pubmed:issue8lld:pubmed
pubmed-article:19470628pubmed:dateCreated2009-8-6lld:pubmed
pubmed-article:19470628pubmed:abstractTextThe point mutation of 3243A>G mtDNA is the most frequent cause of mitochondrial diabetes, often presenting as the syndrome maternally inherited diabetes and deafness (MIDD). The mutation may also cause myopathy, ataxia, strokes, ophthalmoplegia, epilepsy, and cardiomyopathy in various combinations. Consequently, it is difficult to predict the "phenotypic risk profile" of 3243A>G mutation-positive subjects. The 3243A>G mutation coexists in cells with wild-type mtDNA, a phenomenon called heteroplasmy. The marked variability in mutation loads in different tissues is the main explanation for the different phenotypes associated with this mutation.lld:pubmed
pubmed-article:19470628pubmed:languageenglld:pubmed
pubmed-article:19470628pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19470628pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19470628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19470628pubmed:statusMEDLINElld:pubmed
pubmed-article:19470628pubmed:monthAuglld:pubmed
pubmed-article:19470628pubmed:issn1945-7197lld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:SchmitzOleOlld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:AndersenPer...lld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:SchwartzMaria...lld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:KyvikKirsten...lld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:PoulsenPer...lld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:VissingJohnJlld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:JeppesenTina...lld:pubmed
pubmed-article:19470628pubmed:authorpubmed-author:FrederiksenAn...lld:pubmed
pubmed-article:19470628pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19470628pubmed:volume94lld:pubmed
pubmed-article:19470628pubmed:ownerNLMlld:pubmed
pubmed-article:19470628pubmed:authorsCompleteYlld:pubmed
pubmed-article:19470628pubmed:pagination2872-9lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:meshHeadingpubmed-meshheading:19470628...lld:pubmed
pubmed-article:19470628pubmed:year2009lld:pubmed
pubmed-article:19470628pubmed:articleTitleHigh prevalence of impaired glucose homeostasis and myopathy in asymptomatic and oligosymptomatic 3243A>G mitochondrial DNA mutation-positive subjects.lld:pubmed
pubmed-article:19470628pubmed:affiliationDepartment of Endocrinology, Ribe County Hospital, Esbjerg, Finsensgade 35, Esbjerg, Denmark. anja.frederiksen@ouh.regionsyddanmark.dklld:pubmed
pubmed-article:19470628pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19470628pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4567entrezgene:pubmedpubmed-article:19470628lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19470628lld:entrezgene